GlassScriptPhysician profile
Henry V Tran
NPI 1467846709
$9,449.38
in general payments reported to CMS, 2019-2025
13 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $23.50 · 2021: $60.65 · 2022: $334 · 2023: $5,993 · 2024: $2,786 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,400 · Food and Beverage: $515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,400.00 |
| Food and Beverage | $514.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $8,400.00 | 2023-2024 | Clarus, Cirrus Hd-Oct |
| Bausch & Lomb Americas INC. | $233.32 | 2022 | |
| Abbvie INC. | $164.16 | 2022-2023 | Vraylar |
| Johnson & Johnson Vision Care, INC. | $135.37 | 2025 | |
| Sun Pharmaceutical Industries INC. | $120.40 | 2023 | Cequa |
| Apellis Pharmaceuticals, INC. | $89.53 | 2023 | |
| Allergan, INC. | $84.15 | 2020-2021 | |
| Coopervision INC. | $60.87 | 2024 | Clariti Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $56.58 | 2019 | |
| Alcon Vision LLC | $37.69 | 2019-2022 | |
| Harrow Eye, LLC | $29.85 | 2024 | |
| Johnson & Johnson Surgical Vision, INC. | $23.61 | 2019 | |
| Aerie Pharmaceuticals, INC. | $13.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.